G Rechavi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Rechavi

Showing results (191-200 of 194) with videos related to

Pageof 20

Sort By:

You have reached the last page of results.This site can display upto 194 results.

Oncogene|April 11, 2025

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC -R Pradeep, A Zeisel, W J Köstler, et al.

Oncogene|July 12, 2011

Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.

Oncogene|December 6, 2011

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC-R Pradeep, A Zeisel, W J Köstler, et al.

Blood|January 3, 2001

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.

Pageof 20

Search research articles

Showing results (191-200 of 194) with videos related to

Sort By:

Pageof 20

You have reached the last page of results.This site can display upto 194 results.

Oncogene|April 11, 2025

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC -R Pradeep, A Zeisel, W J Köstler, et al.

Oncogene|July 12, 2011

Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.

Oncogene|December 6, 2011

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC-R Pradeep, A Zeisel, W J Köstler, et al.

Blood|January 3, 2001

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.

Pageof 20